The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses
Open accessAbstract
Recent studies on gene molecular profiling using cDNA microarray in a relatively small series of breast cancer have identified biologically distinct groups with apparent clinical and prognostic relevance. The validation of such new taxonomies should be confirmed on larger series of cases prior to acceptance in clinical practice. The development of tissue microarray (TMA) technology provides methodology for high‐throughput concomitant analyses of multiple proteins on large numbers of archival tumour samples. In our study, we have used immunohistochemistry techniques applied to TMA preparations of 1,076 cases of invasive breast cancer to study the combined protein expression profiles of a large panel of well‐characterized commercially available biomarkers related to epithelial cell lineage, differentiation, hormone and growth factor receptors and gene products known to be altered in some forms of breast cancer. Using hierarchical clustering methodology, 5 groups with distinct patterns of protein expression were identified. A sixth group of only 4 cases was also identified but deemed too small for further detailed assessment. Further analysis of these clusters was performed using multiple layer perceptron (MLP)‐artificial neural network (ANN) with a back propagation algorithm to identify key biomarkers driving the membership of each group. We have identified 2 large groups by their expression of luminal epithelial cell phenotypic characteristics, hormone receptors positivity, absence of basal epithelial phenotype characteristics and lack of c‐erbB‐2 protein overexpression. Two additional groups were characterized by high c‐erbB‐2 positivity and negative or weak hormone receptors expression but showed differences in MUC1 and E‐cadherin expression. The final group was characterized by strong basal epithelial characteristics, p53 positivity, absent hormone receptors and weak to low luminal epithelial cytokeratin expression. In addition, we have identified significant differences between clusters identified in this series with respect to established prognostic factors including tumour grade, size and histologic tumour type as well as differences in patient outcomes. The different protein expression profiles identified in our study confirm the biologic heterogeneity of breast cancer and demonstrate the clinical relevance of classification in this manner. These observations could form the basis of revision of existing traditional classification systems for breast cancer. © 2005 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
ELSTON, C. W., & ELLIS, I. O. (1991) · Histopathology · doi:10.1111/j.1365-2559.1991.tb00229.x · Cited by 6,175
Self-citationRepeated observation of breast tumor subtypes in independent gene expression data sets
Sørlie, T., Tibshirani, R., Parker, J., Hastie, T., Marron, J. S., Nobel, A., Deng, S., Johnsen, H., Pesich, R., Geisler, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0932692100 · Cited by 5,429
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Bärlund, M., Schraml, P., Leighton, S., Torhorst, J., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,099
Pathological prognostic factors in breast cancer
Elston, C. (1999) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(99)00034-7 · Cited by 1,735
McCarty, K. S., MILLER, L. S., Cox, E. B., Konrath, J. G., & McCarty, K. S. (1985) · PubMed · Cited by 1,027
Prognostic Factors in Breast Cancer: College of American Pathologists Consensus Statement 1999
Fitzgibbons, P. L., Page, D. L., Weaver, D., Thor, A. D., Allred, D. C., Clark, G. M., Ruby, S. G., O'Malley, F., Simpson, J. F., Connolly, J. L., et al. (2000) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2000-124-0966-pfibc · Cited by 1,016
Validation of Tissue Microarray Technology in Breast Carcinoma
Camp, R. L., Charette, L. A., & Rimm, D. L. (2000) · Laboratory Investigation · doi:10.1038/labinvest.3780204 · Cited by 799
Expression of luminal and basal cytokeratins in human breast carcinoma
Abd El‐Rehim, D. M., Pinder, S. E., Paish, C. E., Bell, J., Blamey, R., Robertson, J. F., Nicholson, R. I., & Ellis, I. O. (2004) · The Journal of Pathology · doi:10.1002/path.1559 · Cited by 594
Self-citationExpression of the HER1–4 family of receptor tyrosine kinases in breast cancer
Witton, C. J., Reeves, J. R., Going, J. J., Cooke, T. G., & Bartlett, J. M. (2003) · The Journal of Pathology · doi:10.1002/path.1370 · Cited by 590
Tissue Microarrays for Rapid Linking of Molecular Changes to Clinical Endpoints
Torhorst, J., Bucher, C., Kononen, J., Haas, P., Zuber, M., Köchli, O. R., Mross, F., Dieterich, H., Moch, H., Mihatsch, M., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63075-1 · Cited by 566
van de Rijn, M., Perou, C. M., Tibshirani, R., Haas, P., Kallioniemi, O., Kononen, J., Torhorst, J., Sauter, G., Zuber, M., Köchli, O. R., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64476-8 · Cited by 560
The Relation between Survival and Age at Diagnosis in Breast Cancer
Adami, H.-O., Malker, B., Holmberg, L., Persson, I., & Stone, B. (1986) · New England Journal of Medicine · doi:10.1056/nejm198608283150906 · Cited by 549
ELLIS, I. O., GALEA, M., BROUGHTON, N., LOCKER, A., BLAMEY, R. W., & ELSTON, C. W. (1992) · Histopathology · doi:10.1111/j.1365-2559.1992.tb01032.x · Cited by 487
Self-citationWesseling, J., van der Valk, S. W., & Hilkens, J. (1996) · Molecular Biology of the Cell · doi:10.1091/mbc.7.4.565 · Cited by 380
Artificial neural networks improve the accuracy of cancer survival prediction
Burke, H. B., Goodman, P. H., Rosen, D. B., Henson, D. E., Weinstein, J. N., Harrell, F. E., Marks, J. R., Winchester, D. P., & Bostwick, D. G. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<857::aid-cncr24>3.0.co;2-y · Cited by 379
Multistep carcinogenesis of breast cancer and tumour heterogeneity
Beckmann, M. W., Niederacher, D., Schnürch, H.-G., Gusterson, B. A., & Bender, H. G. (1997) · Journal of Molecular Medicine · doi:10.1007/s001090050128 · Cited by 299
PINDER, S. E., ELLIS, I. O., GALEA, M., O'ROUKE, S., BLAMEY, R. W., & ELSTON, C. W. (1994) · Histopathology · doi:10.1111/j.1365-2559.1994.tb01269.x · Cited by 287
Self-citationTowards a novel classification of human malignancies based on gene expression patterns
Alizadeh, A. A., Ross, D. T., Perou, C. M., & van de Rijn, M. (2001) · The Journal of Pathology · doi:10.1002/path.889 · Cited by 280
Tan, M., Yao, J., & Yu, D. (1997) · PubMed · Cited by 261
Ball, G., Mian, S., Holding, F., Allibone, R. O., Lowe, J., Ali, S., Li, G., McCardle, S., Ellis, I. O., Creaser, C., et al. (2002) · Bioinformatics · doi:10.1093/bioinformatics/18.3.395 · Cited by 260
Self-citationKorsching, E., Packeisen, J., Agelopoulos, K., Eisenacher, M., Voss, R., Isola, J., van Diest, P. J., Brandt, B., Boecker, W., & Buerger, H. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000038508.86221.b3 · Cited by 238
Pawlowski, V., Révillion-Carette, F., Hebbar, M., Hornez, L., & Peyrat, J. (2000) · PubMed · Cited by 187
Gene expression profiling of primary breast carcinomas using arrays of candidate genes
Bertucci, F. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.20.2981 · Cited by 175
Malzahn, K., Mitze, M., Thoenes, M., & Moll, R. (1998) · Virchows Archiv · doi:10.1007/s004280050226 · Cited by 174
Molecular Classification of Breast Carcinomas Using Tissue Microarrays
Callagy, G., Cattaneo, E., Daigo, Y., Happerfield, L., Bobrow, L. G., Pharoah, P. D. P., & Caldas, C. (2003) · Diagnostic Molecular Pathology · doi:10.1097/00019606-200303000-00004 · Cited by 171
Separating favorable from unfavorable prognostic markers in breast cancer: the role of E-cadherin.
Heimann, R., Lan, F., McBride, R., & Hellman, S. (2000) · PubMed · Cited by 171
Yamashita, H., Nishio, M., Toyama, T., Sugiura, H., Zhang, Z., Kobayashi, S., & Iwase, H. (2003) · Breast Cancer Research · doi:10.1186/bcr738 · Cited by 152
Ginestier, C., Charafe‐Jauffret, E., Bertucci, F., Eisinger, F., Geneix, J., Bechlian, D., Conte, N., Adélaı̈de, J., Toiron, Y., Nguyen, C., et al. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64399-4 · Cited by 144
Loss of Antigenicity in Stored Sections of Breast Cancer Tissue Microarrays
Fergenbaum, J., García‐Closas, M., Hewitt, S. M., Lissowska, J., Sakoda, L. C., & Sherman, M. E. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.667.13.4 · Cited by 136
Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines.
Kondo, K., Kohno, N., Yokoyama, A., et al. (1998) · PubMed · Cited by 134
Goffin, J. R., Chappuis, P. O., Bégin, L. R., Wong, N., Brunet, J., Hamel, N., Paradis, A.-J., Boyd, J. A., & Foulkes, W. D. (2003) · Cancer · doi:10.1002/cncr.11080 · Cited by 111
Bull, S. B., Özçelik, H., Pinnaduwage, D., Blackstein, M. E., Sutherland, D. A. J., Pritchard, K. I., Tzontcheva, A., Sidlofsky, S., Hanna, W. M., Qizilbash, A. H., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2004.09.128 · Cited by 99
Modeling complex environmental data
Roadknight, C., Balls, G., Mills, G., & Palmer-Brown, D. (1997) · IEEE Transactions on Neural Networks · doi:10.1109/72.595883 · Cited by 98
BRCA1 expression levels predict distant metastasis of sporadic breast cancers
Seery, L. T., Knowlden, J. M., Gee, J. M. W., Robertson, J. F. R., Kenny, F. S., Ellis, I. O., & Nicholson, R. I. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990621)84:3<258::aid-ijc10>3.0.co;2-h · Cited by 64
Self-citationBalls, G., Palmer-Brown, D., & Sanders, G. E. (1996) · New Phytologist · doi:10.1111/j.1469-8137.1996.tb01846.x · Cited by 61
Proliferative lifespan checkpoints: Cell-type specificity and influence on tumour biology
Wynford‐Thomas, D. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00064-6 · Cited by 53
Olsson, H. L. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00111-4 · Cited by 28
Immunohistochemical analysis of cytokeratin #8 as a prognostic factor in invasive breast carcinoma.
Takei, H., Iino, Y., Horiguchi, J., Kanoh, T., Takao, Y., Oyama, T., & Morishita, Y. (1995) · PubMed · Cited by 25
Cited by
Triple-negative breast cancer: clinical features and patterns of recurrence
Dent, R., Trudeau, M., Pritchard, K. I., Hanna, W. M., Kahn, H. K., Sawka, C. A., Lickley, L. A., Rawlinson, E., Sun, P., & Narod, S. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-3045 · Cited by 5,091
Foulkes, W. D., Smith, I. E., & Reis-Filho, J. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra1001389 · Cited by 4,157
Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., Somerfield, M. R., Hayes, D. F., & Bast, R. C. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2364 · Cited by 2,217
Tumor-Infiltrating CD8+Lymphocytes Predict Clinical Outcome in Breast Cancer
Mahmoud, S. M. A., Paish, E. C., Powe, D. G., Macmillan, R. D., Grainge, M. J., Lee, A. H. S., Ellis, I. O., & Green, A. R. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.5037 · Cited by 1,367
Self-citationPrognostic markers in triple‐negative breast cancer
Rakha, E. A., El‐Sayed, M. E., Green, A. R., Lee, A. H. S., Robertson, J. F., & Ellis, I. O. (2007) · Cancer · doi:10.1002/cncr.22381 · Cited by 1,283
Self-citation
Metadata
- Authors
- Abd El‐Rehim, D. M., Ball, G., Pinder, S. E., Rakha, E., Paish, C., Robertson, J. F. R., Macmillan, D., Blamey, R. W., & Ellis, I. O.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2005-06-10
- Volume
- 116
- Issue
- 3
- Pages
- 340-350
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2059272061
- Cited by
- 606
- References
- 43
- FWCI
- 19.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.